CONDUIT PHARMACEUTICALS INC. 10-K Cybersecurity GRC - 2024-04-16

Page last updated on April 16, 2024

CONDUIT PHARMACEUTICALS INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-16 17:29:58 EDT.

Filings

10-K filed on 2024-04-16

CONDUIT PHARMACEUTICALS INC. filed an 10-K at 2024-04-16 17:29:58 EDT
Accession Number: 0001493152-24-014889

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity We operate in the biotechnology sector, which is subject to various cybersecurity risks that could adversely affect our business, financial condition, and results of operations, including intellectual property theft fraud extortion harm to employees or customers violation of privacy laws and other litigation and legal risk and reputational risk. We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We require third-party service providers with access to personal, confidential or proprietary information to implement and maintain comprehensive cybersecurity practices consistent with applicable legal standards and industry best practices. The Company is currently in the process of implementing a more formalized cybersecurity program. In light of the pervasive and increasing threat from cyberattacks, the Board and the Audit Committee, with input from management, assess the Company s cybersecurity threats and the measures implemented by the Company to mitigate and prevent cyberattacks. The Audit Committee consults with management regarding ongoing cybersecurity initiatives, and requests management to report to the Audit Committee or the full Board regularly on their assessment of the Company s cybersecurity program and risks. As of the date of this Annual Report, the Company is not aware of any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.

Company Information